These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32937623)

  • 1. Risk Factors for Safety of Allergen-Specific Sublingual Immunotherapy in Children with Allergic Rhinitis.
    Liu W; Zeng Q; Yan S; Sun C; Tang Y; Luo R
    Int Arch Allergy Immunol; 2020; 181(12):934-940. PubMed ID: 32937623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for Short-Term Efficacy of Allergen-Specific Sublingual Immunotherapy in Children with Allergic Rhinitis.
    Liu W; Zeng Q; Luo R
    Mediators Inflamm; 2020; 2020():1847061. PubMed ID: 32377158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Efficacy of Sublingual Mite Immunotherapy in Monosensitized and Polysensitized Children with Allergic Rhinitis: A 7-Year Prospective Study.
    Cui L; Li J; Li Y; Xia Z
    Int Arch Allergy Immunol; 2019; 180(2):144-149. PubMed ID: 31256165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.
    Đurić-Filipović I; Caminati M; Kostić G; Filipović Đ; Živković Z
    World J Pediatr; 2016 Aug; 12(3):283-290. PubMed ID: 27351563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sublingual immunotherapy with Dermatophagoides farinae drops in pre-school and school-age children with allergic rhinitis.
    Tang LX; Yang XJ; Wang PP; Ge WT; Zhang J; Guo YL; Lu J; Tai J; Zhang YM; Ni X
    Allergol Immunopathol (Madr); 2018; 46(2):107-111. PubMed ID: 29331618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.
    Maloney J; Durham S; Skoner D; Dahl R; Bufe A; Bernstein D; Murphy K; Waserman S; Berman G; White M; Kaur A; Nolte H
    Allergy; 2015 Mar; 70(3):302-9. PubMed ID: 25495666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases.
    Li P; Li Q; Huang Z; Chen W; Lu Y; Tian M
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):796-801. PubMed ID: 25145986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
    Wang ZX; Shi H
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictivity of clinical efficacy of sublingual immunotherapy (SLIT) based on sensitisation pattern to molecular allergens in children with allergic rhinoconjunctivitis.
    di Coste A; Occasi F; De Castro G; Zicari AM; Galandrini R; Giuffrida A; Indinnimeo L; Duse M
    Allergol Immunopathol (Madr); 2017; 45(5):452-456. PubMed ID: 28410874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites.
    Maloney J; Prenner BM; Bernstein DI; Lu S; Gawchik S; Berman G; Kaur A; Li Z; Nolte H
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):59-65. PubMed ID: 26553448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy, safety and compliance of immunotherapy in the treatment of allergic rhinitis: a Meta-analysis].
    Ji DX; Tan JR; Yu HW
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Dec; 54(12):894-901. PubMed ID: 31887814
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
    Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
    Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. House dust mite sublingual immunotherapy in allergic rhinitis.
    Cho SW; Han DH; Kim JW; Kim DY; Rhee CS
    Immunotherapy; 2018 Jun; 10(7):567-578. PubMed ID: 29562802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of sublingual immunotherapy in children and adult patients with allergic rhinitis.
    Lin X; Lin H; Wei X; Huang Q
    Allergol Immunopathol (Madr); 2017; 45(5):457-462. PubMed ID: 28237130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.
    Emminger W; Hernández MD; Cardona V; Smeenk F; Fogh BS; Calderon MA; de Blay F; Backer V
    Int Arch Allergy Immunol; 2017; 174(1):35-44. PubMed ID: 28950268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
    Gotoh M; Okubo K; Yuta A; Ogawa Y; Nagakura H; Ueyama S; Ueyama T; Kawashima K; Yamamoto M; Fujieda S; Sakashita M; Sakamoto H; Iwasaki N; Mori E; Endo T; Ohta N; Kitazawa H; Okano M; Asako M; Takada M; Terada T; Inaka Y; Yonekura S; Matsuoka T; Kaneko S; Hata H; Hijikata N; Tanaka H; Masuyama K; Okamoto Y
    Allergol Int; 2020 Jan; 69(1):104-110. PubMed ID: 31421989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 29025463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.